Cathie Wood Is Buying This Stock Hand Over Fist. Should You?
Superstar investor Cathie Wood is increasing her bet on a cutting-edge technology that could transform the treatment of many diseases. I'm talking about gene editing.
Wood has been progressively increasing her stake in specialist Intellia Therapeutics (NASDAQ: NTLA) since December. But she's picked up the pace of Intellia buys over the past month and scooped up more than 434,000 shares.
The company's stock has dropped about 17% since its peak in July, so Wood clearly saw this as an opportunity to add to her position in the biotech company. Considering Wood's strengths in picking out top innovators -- she was an early believer in electric-vehicle giant Tesla, for example -- you may be tempted to follow her latest moves. But should you, too, pile into Intellia shares right now?
Source Fool.com
Intellia Therapeutics Inc Stock
With 17 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 60 € there is potential for a 146.91% increase which would mean more than doubling the current price of 24.3 € for Intellia Therapeutics Inc.
